Content continues after advertisement

Compounding for the Small Animal Practitioner

Compounding for the Small Animal Practitioner

Travis Watson, PharmD, Golden Gate Veterinary Compounding Pharmacy

Pharmacology & Medications

|March 2016|Peer Reviewed

Sign in to Print/View PDF


“How do I adapt the vast array of human and veterinary medications to fit my patients' needs?" 

This is a common question that plagues most, if not all, small animal practitioners during the course of their careers. There likely will always be problems with finding the right drug formulation at, for example, the appropriate strength or one the patient will not refuse.


Compounding Defined

Each patient is unique, and in many cases, the available commercially prepared medications may not fit all patient needs. Compounding is the tailoring of an existing drug to fit the specific needs of an individual patient. In veterinary medicine, this could involve the creation of noncommercially available formulations such as

  • Capsules or tablets, compounded to patient-specific strengths, sizes, and/or combinations
  • Oral liquids (eg, suspensions, solutions)
  • Medicated treats, which improve palatability and acceptance
  • Transdermal gels (eg, methimazole), which help avoid oral and GI involvement1

Compounding is the tailoring of an existing drug to fit the specific needs of an individual patient.

Not every drug can be safely or effectively compounded. 

For those that can, properties, including pharmacokinetics and pharmacodynamics, can be altered.1 In some instances (eg, when using transdermal methimazole), efficacy can be evaluated with clinical monitoring (in this case, a thyroid panel). It is important to evaluate each drug and discuss the options with a compounder before choosing a compounded product.

A big misconception about compounding is that it is synonymous with use of a generic drug. 

A generic drug, like its brand name counterpart, is a manufactured drug. Manufactured drugs are made on a large-scale, regulated by the FDA, and intended to be distributed to many patients. Compounding, however, is done on a much smaller scale, is not directly regulated by the FDA, and is intended for individual patients. For example, tramadol 50-mg tablets are commercially available from many manufacturers, either as the brand name or as the generic tramadol HCl identified by a National Drug Code. However, the tablet strength is too high for many smaller patients, so a tramadol 10-mg/mL suspension offers a safer option. The suspension formulation, however, is not available from a large-scale manufacturer and therefore would have to be formulated by a compounding pharmacy and customized on an individual patient basis.


  • Only compound if there is no human- or veterinary-labeled drug available in an appropriate formulation.
  • All compounding must be done by a licensed pharmacist or veterinarian.
  • All compounds must be for individual patients within a valid veterinarian–client–patient relationship.*
  • Follow all relevant state and federal laws. All dispensed medications must be adequately labeled.

*Some states allow “For Office Use” compounds. See individual state regulations for further details.


With so many options and the lack of FDA regulation, many practitioners are hesitant to turn to compounding, questioning the consistency and quality of compounded products. Compounding should not be looked on as a flawless science, but the prescriber and compounder can work together to deliver quality therapy. It is crucial to abide by the Animal Medical Drug Use Clarification Act (AMDUCA) and all appropriate FDA compliance guidelines regarding veterinary compounding. In addition, the US Pharmacopeial (USP) Convention standardizes the ingredients, techniques, and evaluation of compounding practices.2 The USP guidelines provide the foundation for consistency and good compounding practices. Most state boards of pharmacy, as well as the AVMA, recognize the USP guidelines as enforceable procedures for compounding.3 

AMDUCA = Animal Medical, Drug Use Clarification Act,  AVMA = American Veterinary Medical Association, FDA = Food and Drug Administration, USP = US Pharmacopeial  

References and Author Information

For global readers, a calculator to convert laboratory values, dosages, and other measurements to SI units can be found here.

All Clinician's Brief content is reviewed for accuracy at the time of publication. Previously published content may not reflect recent developments in research and practice.

Material from Clinician's Brief may not be reproduced, distributed, or used in whole or in part without prior permission of Educational Concepts, LLC. For questions or inquiries please contact us.


Clinician's Brief:
The Podcast
Listen as host Alyssa Watson, DVM, talks with the authors of your favorite Clinician’s Brief articles. Dig deeper and explore the conversations behind the content here.
Clinician's Brief provides relevant diagnostic and treatment information for small animal practitioners. It has been ranked the #1 most essential publication by small animal veterinarians for 9 years.*

*2007-2017 PERQ and Essential Media Studies

© 2023 Educational Concepts, L.L.C. dba Brief Media ™ All Rights Reserved. Terms & Conditions | DMCA Copyright | Privacy Policy | Acceptable Use Policy